Finance

Lists
XLO:NASDAQ
Xilio Therapeutics Inc
$9.23
0.00%
(0.00) 1D
$9.48
+2.72% (+0.25)
After hours
Closed: Aug 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XLO...
Open
$9.21
High
$9.23
Low
$9.07
Mkt. cap
60.73M
Avg. vol.
30.00K
Volume
5.22K
52-wk high
$12.74
52-wk low
$6.47
EPS
-$1.54
Beta
-0.12
Shares outstanding
6.58M
No. of employees
76
Open
$9.21
High
$9.23
Low
$9.07
Mkt. cap
60.73M
Avg. vol.
30.00K
Volume
5.22K
52-wk high
$12.74
52-wk low
$6.47
EPS
-$1.54
Beta
-0.12
Shares outstanding
6.58M
No. of employees
76
News stories
From web sources and news partners
About Xilio Therapeutics Inc
CEO-
Employees76
Founded2016
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitexiliotx.com
Analyst
Recommendation
Action
Price target
Projected
Date
Marc Frahm
TD Cowen
Buy
Maintained
-
-
11/13/2025
Last report
Aug 12, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$0.33 / -$1.68
+80.36%beat
Revenue / Est. (USD)
18.69M / 12.72M
+46.95%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.07M
13.69M
12.65M
18.69M
Cost of goods sold
14.32M
-37.92M
19.83M
14.56M
Cost of revenue
14.32M
-37.92M
19.83M
14.56M
Research and development expenses
-
56.04M
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.67M
7.40M
6.93M
7.62M
Operating expense
6.67M
63.44M
6.93M
7.62M
Total operating expenses
21.00M
25.52M
26.76M
22.18M
Operating income
-1.93M
-11.84M
-14.11M
-3.49M
Other non operating income
-14.36M
24.70M
3.30M
-2.88M
EBT including unusual items
-16.29M
10.36M
-9.53M
-6.37M
EBT excluding unusual items
-16.29M
10.36M
-9.53M
-6.37M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16.29M
10.36M
-9.53M
-6.37M
Net profit margin
-85.42%
75.70%
-75.34%
-34.09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.28M
-
Interest expense
-
-2.50M
-
-
Net interest expenses
-
-2.50M
1.28M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.59M
-11.51M
-13.77M
-3.16M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps